A randomized trial of hybrid administration of cyclophosphamide, doxorubicin, and vincristine (CAV)/Cisplatin and etoposide (PVP) versus sequential administration of CAV-PVP for the treatment of patients with small cell lung carcinoma: Results of long term follow-up

Hiroshi Ueoka, Katsuyuki Kiura, Masahiro Tabata, Haruhito Kamei, Kenichi Gemba, Katsuyoshi Sakae, Yoshio Hiraki, Shunkichi Hiraki, Yoshihiko Segawa, Mine Harada

Research output: Contribution to journalArticlepeer-review

20 Citations (Scopus)

Fingerprint Dive into the research topics of 'A randomized trial of hybrid administration of cyclophosphamide, doxorubicin, and vincristine (CAV)/Cisplatin and etoposide (PVP) versus sequential administration of CAV-PVP for the treatment of patients with small cell lung carcinoma: Results of long term follow-up'. Together they form a unique fingerprint.

Medicine & Life Sciences